Revolution Medicines Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Revolution Medicines stock have an average target of 67.77, with a low estimate of 48 and a high estimate of 87. The average target predicts an increase of 91.82% from the current stock price of 35.33.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$48	$67.77	$70	$87
Change	+35.86%	+91.82%	+98.13%	+146.25%

Analyst Ratings

The average analyst rating for Revolution Medicines stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	6	6	7	7	8	8
Buy	7	7	6	6	5	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	13	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $72 → $73	Strong Buy	Maintains	$72 → $73	+106.62%	Mar 3, 2025
Benjamin Burnett Stifel	Stifel	Strong Buy Maintains $80 → $78	Strong Buy	Maintains	$80 → $78	+120.78%	Feb 27, 2025
Ami Fadia Needham	Needham	Strong Buy Maintains $60 → $59	Strong Buy	Maintains	$60 → $59	+67.00%	Feb 27, 2025
Eliana Merle UBS	UBS	Strong Buy Maintains $65 → $71	Strong Buy	Maintains	$65 → $71	+100.96%	Jan 8, 2025
Robert Driscoll Wedbush	Wedbush	Buy Maintains $70 → $67	Buy	Maintains	$70 → $67	+89.64%	Dec 6, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

1.31M

Revenue Next Year

3.32M

from 1.31M

153.09%

from 1.31M

EPS This Year

-4.04

from -3.58

EPS Next Year

-4.31

from -4.04

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	42.98M	29.39M	35.38M	11.58M	-	1.31M	3.32M	135.30M
Revenue Growth	-14.10%	-31.62%	20.38%	-67.27%	-	-	153.09%	3,977.76%
EPS	-2.01	-2.57	-3.08	-3.86	-3.58	-4.04	-4.31	-3.03
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	18	15	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	18.9M	43.6M	570.2M
Avg	1.3M	3.3M	135.3M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	3,223.8%	17,083.5%
Avg	-	153.1%	3,977.8%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-3.78	-4.02	1.46
Avg	-4.04	-4.31	-3.03
Low	-4.56	-4.64	-5.34

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.